日本語English简体中文 繁體中文

4599 StemRIM Inc.ステムリムTSE Growth / Pharmaceuticals

0 posts

StemRIM Inc. (4599) at a glance

Code
4599
Company
StemRIM Inc.
Local name
ステムリム
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥122 -4.0 (-3.17%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

StemRIM Inc. (4599) Stock Price History

StemRIM Inc. closed at ¥122 on Nov 20, 2026, −20.8% over 1 month, −56.0% over 1 year.

¥154¥111Oct 20Nov 20
Price5-day MA25-day MANikkei 225
1-Month High¥154Oct 20
1-Month Low¥111Nov 6
1-Week Change+4.3%vs Nov 13
1-Month Change−20.8%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥79,221 today (−20.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −20.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥122−4−3.17%
Nov 18 (Wed)¥126+4+3.28%
Nov 17 (Tue)¥122+0+0.00%
Nov 16 (Mon)¥122+5+4.27%
Nov 13 (Fri)¥117−2−1.68%
Nov 12 (Thu)¥119+0+0.00%
Nov 10 (Tue)¥119+3+2.59%
Nov 9 (Mon)¥116+5+4.50%
Nov 6 (Fri)¥111−12−9.76%
Nov 5 (Thu)¥123−7−5.38%
2026-09-09 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行に関する… / 2026年7月期 決算短信〔日本基準〕(非連結) / 当社取締役に対するストック・オプション(新株予約権)の発行に関するお知らせ2026-09-10 当社取締役に対するストック・オプション(新株予約権)の発行内容確定に関するお知… / 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行内容確定…2026-09-25 執行役員、従業員及び社外協力者に対するストック・オプションとしての新株予約権に…¥357¥111Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥357Aug 21
3-Month Low¥111Nov 6
1-Month Change−20.8%vs Oct 20
3-Month Change−65.6%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥34,366 today (−65.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −65.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥122−4−3.17%
Nov 18 (Wed)¥126+4+3.28%
Nov 17 (Tue)¥122+0+0.00%
Nov 16 (Mon)¥122+5+4.27%
Nov 13 (Fri)¥117−2−1.68%
Nov 12 (Thu)¥119+0+0.00%
Nov 10 (Tue)¥119+3+2.59%
Nov 9 (Mon)¥116+5+4.50%
Nov 6 (Fri)¥111−12−9.76%
Nov 5 (Thu)¥123−7−5.38%
2026-09-09 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行に関する… / 2026年7月期 決算短信〔日本基準〕(非連結) / 当社取締役に対するストック・オプション(新株予約権)の発行に関するお知らせ2026-09-10 当社取締役に対するストック・オプション(新株予約権)の発行内容確定に関するお知… / 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行内容確定…2026-09-25 執行役員、従業員及び社外協力者に対するストック・オプションとしての新株予約権に…¥357¥111May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥357Aug 21
6-Month Low¥111Nov 6
3-Month Change−65.6%vs Aug 20
6-Month Change−57.2%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥42,807 today (−57.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −57.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥122−12.2%
Oct 2026¥139−18.2%
Sep 2026¥170−48.8%
Aug 2026¥332+11.4%
Jul 2026¥298−8.0%
Jun 2026¥324+9.5%
May 2026¥296−1.3%
2026-09-09 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行に関する… / 2026年7月期 決算短信〔日本基準〕(非連結) / 当社取締役に対するストック・オプション(新株予約権)の発行に関するお知らせ2026-09-10 当社取締役に対するストック・オプション(新株予約権)の発行内容確定に関するお知… / 当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行内容確定…2026-09-25 執行役員、従業員及び社外協力者に対するストック・オプションとしての新株予約権に…¥357¥111Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥357Aug 21
52-Week Low¥111Nov 6
Year to Date−53.6%vs Dec 30
From 52-Week High−65.8%Aug 21

If you had invested ¥100,000 1 year ago, it would be worth ¥44,043 today (−56.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −56.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥122−12.2%
Oct 2026¥139−18.2%
Sep 2026¥170−48.8%
Aug 2026¥332+11.4%
Jul 2026¥298−8.0%
Jun 2026¥324+9.5%
May 2026¥296−1.3%
Apr 2026¥300+2.4%
Mar 2026¥293−4.6%
Feb 2026¥307+5.9%
Jan 2026¥290+10.3%
Dec 2025¥263−6.1%
Nov 2025¥280―
¥682¥111Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥682Nov 20, 2023
3-Year Low¥111Nov 6, 2026
Annualized Return−43.6%
Max Drawdown−83.7%

If you had invested ¥100,000 3 years ago, it would be worth ¥17,889 today (−82.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −82.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥122−53.6%
2025¥263―
¥1,380¥111Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥1,380Apr 10, 2023
5-Year Low¥111Nov 6, 2026
Annualized Return−25.9%
Max Drawdown−92.0%

If you had invested ¥100,000 5 years ago, it would be worth ¥22,385 today (−77.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −77.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥122−53.6%
2025¥263―
¥1,380¥111Aug 5, 2019Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥1,380Apr 2023
All-Time Low¥111Nov 2026
Total Change−87.2%vs Aug 2019
Annualized Return−24.5%

If you had invested ¥100,000 in Aug 2019, it would be worth ¥12,829 today (−87.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +159.4%, while this stock moved −87.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥122−53.6%
2025¥263−16.2%
2024¥314−45.7%
2023¥578−35.7%
2022¥899+2.0%
2021¥881+37.4%
2020¥641−30.3%
2019¥920―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Aug 2019). Please check the latest prices before trading.

StemRIM Inc. (4599) financial indicators

PBR
1.84
Dividend yield
0.00%

See all financial indicators for StemRIM Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of StemRIM Inc. (4599)

Business overview

The company is a drug developer researching "regeneration-inducing medicines". Instead of administering living cells, these drugs activate stem cells already in the patient's body to promote regeneration of damaged tissue, a new mechanism of action. It hopes they will work across a wide range of diseases, including central nervous system disorders such as stroke and ALS, cardiovascular disease such as heart attacks, intractable skin ulcers, chronic liver disease, bone and cartilage injuries and pulmonary fibrosis.

Summarized from the annual securities report (fiscal year ended July 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR1.84xBelow the sector median of 1.86x (No. 38 from the lowest)
Market cap¥7.6 bnNo. 50 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3578/28
52-week low¥11111/6
Current position4.5%Where the low is 0% and the high is 100% (close on 11/20: ¥122)
Year to date-53.6%No. 70 of 77 in the sector (best first)
1 year-56.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Show 4 more
  • 09/10 17:00当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行内容確定に関するお知らせ
  • 09/09 16:00当社執行役員及び従業員に対するストック・オプション(新株予約権)の発行に関するお知らせ
  • 09/09 16:002026年7月期 決算短信〔日本基準〕(非連結)
  • 09/09 16:00当社取締役に対するストック・オプション(新株予約権)の発行に関するお知らせ

Filings from the past 12 months (14).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the StemRIM Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English